Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$33.15 - $49.5 $21,481 - $32,076
-648 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$28.67 - $34.32 $13,933 - $16,679
-486 Reduced 42.86%
648 $21,000
Q2 2020

Aug 14, 2020

SELL
$23.48 - $33.86 $16,929 - $24,413
-721 Reduced 38.87%
1,134 $31,000
Q4 2019

Feb 12, 2020

SELL
$31.89 - $47.34 $2,296 - $3,408
-72 Reduced 3.74%
1,855 $61,000
Q3 2019

Nov 14, 2019

SELL
$32.06 - $44.0 $244,681 - $335,808
-7,632 Reduced 79.84%
1,927 $71,000
Q2 2019

Aug 13, 2019

BUY
$37.68 - $46.52 $32,065 - $39,588
851 Added 9.77%
9,559 $415,000
Q1 2019

May 14, 2019

BUY
$39.84 - $51.04 $160,634 - $205,793
4,032 Added 86.23%
8,708 $370,000
Q4 2018

Feb 14, 2019

SELL
$41.16 - $66.67 $119,322 - $193,276
-2,899 Reduced 38.27%
4,676 $208,000
Q3 2018

Nov 15, 2018

BUY
$55.13 - $72.65 $417,609 - $550,323
7,575 New
7,575 $518,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $868M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.